Author(s): Brannon-Peppas L, Blanchette JO
This review explores recent work directed towards more targeted treatment of cancer, whether through more specific anti-cancer agents or through methods of delivery. These areas include delivery by avoiding the reticuloendothelial system, utilizing the enhanced permeability and retention effect and tumor-specific targeting. Treatment opportunities using antibody-targeted therapies are summarized. The ability to treat cancer by targeting delivery through angiogenesis is also discussed and antiangiogenic drugs in clinical trials are presented. Delivery methods that specifically use nanoparticles are also highlighted, including both degradable and nondegradable polymers.
Author(s): Hanahan D, Weinberg RA
Author(s): Burstein HJ
Author(s): Cheon J, Lee JH
Author(s): Kayser O, Lemke A, Hernandez-Trejo N
Author(s): Cho K, Wang X, Nie S, Chen ZG, Shin DM
Author(s): Dunpall R, Lewis EA, Haigh SJ, O'Brien P, Revaprasadu N
Author(s): Cho SH, Jones BL, Krishnan S
Author(s): Dunpall R, Revaprasadu N
Author(s): Rambharose S, Kalhapure RS, Akamanchi KG, Govender T
Author(s): Zhou JD, Wang SH, Liu R, Zhou CJ, Cao K, et al.
Author(s): Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L
Author(s): Chen C, Xing G, Wang J, Zhao Y, Li B, et al.
Author(s): Ortiz R, Cabeza L, Arias JL, Melguizo C, Álvarez PJ, et al.
Author(s): Wang Y, Li P, Chen L, Gao W, Zeng F
Author(s): Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P,et al.
Author(s): He C, Liu D, Lin W
Author(s): Zhang J, Srivastava R, Misra R
Author(s): Shen S, Tang H, Zhang X, Ren J, Pang Z, et al.
Author(s): Banerji B, Pramanik SK, Mandal S, Maiti NC, Chaudhuri K
Author(s): Trail PA
